Compare TARA & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TARA | MDV |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.5M | 149.6M |
| IPO Year | N/A | 2022 |
| Metric | TARA | MDV |
|---|---|---|
| Price | $5.48 | $14.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $20.33 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 33.9K |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | N/A | ★ 7.86% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $47,479,000.00 |
| Revenue This Year | N/A | $0.13 |
| Revenue Next Year | N/A | $0.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.77 | $13.62 |
| 52 Week High | $7.82 | $17.15 |
| Indicator | TARA | MDV |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 58.71 |
| Support Level | $5.07 | $14.50 |
| Resistance Level | $6.37 | $15.10 |
| Average True Range (ATR) | 0.46 | 0.32 |
| MACD | -0.19 | 0.04 |
| Stochastic Oscillator | 15.99 | 76.00 |
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.